RASSF1 and hepatocellular carcinoma: In summary, TET1-CD can exert integrated anticancer effects through activation of hypermethylated APC, p16, RASSF1A, SOCS1 and TET1 gene, and a single transient transfection of TET1-CD may open a new possibility for HCC treatment.